1
|
Alitalo O, Kohtala S, Rosenholm M, Saarreharju R, González-Hernández G, Sarparanta M, Rozov S, Rantamäki T. Nitrous oxide induces hypothermia and TrkB activation: Maintenance of body temperature abolishes antidepressant-like effects in mice. Neuropharmacology 2024; 261:110172. [PMID: 39362627 DOI: 10.1016/j.neuropharm.2024.110172] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/20/2024] [Revised: 09/24/2024] [Accepted: 09/27/2024] [Indexed: 10/05/2024]
Abstract
Recent studies indicate that nitrous oxide (N2O), a gaseous anesthetic and an NMDA (N-methyl-D-aspartate) receptor antagonist, produces rapid antidepressant effect in patients suffering from treatment-resistant depression. Our recent work implies that hypothermia and reduced energy expenditure are connected with antidepressant-induced activation of TrkB neurotrophin receptors - a key regulator of synaptic plasticity. In this study, we demonstrate that a brief exposure to N2O leads to a drop in body temperature following the treatment, which is linked to decreased locomotor activity; enhanced slow-wave electroencephalographic activity; reduced brain glucose utilization; and increased phosphorylation of TrkB, GSK3β (glycogen synthase kinase 3β), and p70S6K (a kinase downstream of mTor (mammalian target of rapamycin)) in the medial prefrontal cortex of adult male mice. Moreover, preventing the hypothermic response in a chronic corticosterone stress model of depression attenuated the antidepressant-like behavioral effects of N2O in the saccharin preference test. These findings indicate that N2O treatment modulates TrkB signaling and related neurotrophic signaling pathways in a temperature-dependent manner, suggesting that the phenomenon driving TrkB activation - altered thermoregulation and energy expenditure - is linked to antidepressant-like behavioral responses.
Collapse
Affiliation(s)
- Okko Alitalo
- Laboratory of Neurotherapeutics, Drug Research Program, Division of Pharmacology and Pharmacotherapy, Faculty of Pharmacy, University of Helsinki, Finland; SleepWell Research Program, Faculty of Medicine, University of Helsinki, Finland
| | - Samuel Kohtala
- Laboratory of Neurotherapeutics, Drug Research Program, Division of Pharmacology and Pharmacotherapy, Faculty of Pharmacy, University of Helsinki, Finland; SleepWell Research Program, Faculty of Medicine, University of Helsinki, Finland
| | - Marko Rosenholm
- Laboratory of Neurotherapeutics, Drug Research Program, Division of Pharmacology and Pharmacotherapy, Faculty of Pharmacy, University of Helsinki, Finland; SleepWell Research Program, Faculty of Medicine, University of Helsinki, Finland; Center for Translational Neuromedicine, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark
| | - Roosa Saarreharju
- Laboratory of Neurotherapeutics, Drug Research Program, Division of Pharmacology and Pharmacotherapy, Faculty of Pharmacy, University of Helsinki, Finland; SleepWell Research Program, Faculty of Medicine, University of Helsinki, Finland
| | - Gemma González-Hernández
- Laboratory of Neurotherapeutics, Drug Research Program, Division of Pharmacology and Pharmacotherapy, Faculty of Pharmacy, University of Helsinki, Finland; SleepWell Research Program, Faculty of Medicine, University of Helsinki, Finland; Neuropsychopharmacology and Psychobiology Research Group, Department of Neurosciences, University of Cádiz, Cádiz, Spain
| | | | - Stanislav Rozov
- Laboratory of Neurotherapeutics, Drug Research Program, Division of Pharmacology and Pharmacotherapy, Faculty of Pharmacy, University of Helsinki, Finland; SleepWell Research Program, Faculty of Medicine, University of Helsinki, Finland
| | - Tomi Rantamäki
- Laboratory of Neurotherapeutics, Drug Research Program, Division of Pharmacology and Pharmacotherapy, Faculty of Pharmacy, University of Helsinki, Finland; SleepWell Research Program, Faculty of Medicine, University of Helsinki, Finland.
| |
Collapse
|
2
|
Serafini D, Zancopè N, Pavone AM, Benfante V, Arzenton A, Russo V, Ballan M, Morselli L, Cammarata FP, Comelli A, Russo G, Scopelliti F, Di Marco V, Mastrotto F, Asti M, Maniglio D, Sbarra C, Bortolussi S, Donzella A, Zenoni A, Gandini A, Villa V, Paderno D, Zangrando L, Corradetti S, Mariotti E, Salvini A, Torrisi F, Lunardon M, Andrighetto A. 111Ag phantom images with Cerenkov Luminescence Imaging and digital autoradiography within the ISOLPHARM project. Appl Radiat Isot 2024; 215:111562. [PMID: 39488936 DOI: 10.1016/j.apradiso.2024.111562] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/15/2024] [Revised: 10/08/2024] [Accepted: 10/21/2024] [Indexed: 11/05/2024]
Abstract
Targeted Radionuclide Therapy (TRT) is a medical technique exploiting radionuclides to combat cancer growth and spread. TRT requires a supply of radionuclides that are currently produced by either cyclotrons or nuclear research reactors. In this context, the ISOLPHARM project investigates the production of innovative radionuclides for medical applications. This production will be based on the forthcoming SPES facility at the Legnaro National Laboratories (LNL) of the National Institute for Nuclear Physics (INFN), an ISOL facility where high-purity radioactive beams will be used to produce carrier-free radiopharmaceuticals. Previous studies demonstrated that a significant amount of 111Ag, an innovative β/γ emitter suitable for TRT with theranostic applications, can be obtained at the SPES facility. The present work describes the first imaging study on phantoms with 111Ag performed by the ISOLPHARM collaboration. This is a fundamental step to pave the way for the upcoming in vivo studies on the 111Ag-based radiopharmaceutical currently being developed. The imaging potential of this radionuclide was investigated by acquiring phantom images with Cerenkov Luminescence Imaging (CLI) and digital autoradiography (ARG).
Collapse
Affiliation(s)
- Davide Serafini
- Legnaro National Laboratories, National Institute for Nuclear Physics, INFN-LNL, Viale dell'Università 2, 35020 Legnaro, Italy; Department of Physical Sciences, Earth and Environment, University of Siena, Via Roma 56, 53100 Siena, Italy.
| | - Nicola Zancopè
- Department of Physics and Astronomy, University of Padova, Via Marzolo 8, 35131 Padova, Italy.
| | - Anna Maria Pavone
- Department of Biomedical and Biotechnological Sciences, University of Catania, Via Santa Sofia 97, 95123 Catania, Italy; Ri.MED Foundation, Via Bandiera 11, 90133 Palermo, Italy.
| | - Viviana Benfante
- Ri.MED Foundation, Via Bandiera 11, 90133 Palermo, Italy; Institute of Molecular Bioimaging and Physiology, National Research Council. IBFM-CNR, Contrada Pietrapollastra-Pisciotto, 90015 Cefalù, Italy.
| | - Alberto Arzenton
- Legnaro National Laboratories, National Institute for Nuclear Physics, INFN-LNL, Viale dell'Università 2, 35020 Legnaro, Italy; Department of Physical Sciences, Earth and Environment, University of Siena, Via Roma 56, 53100 Siena, Italy.
| | - Vincenzo Russo
- Department of Biomedical and Biotechnological Sciences, University of Catania, Via Santa Sofia 97, 95123 Catania, Italy.
| | - Michele Ballan
- Legnaro National Laboratories, National Institute for Nuclear Physics, INFN-LNL, Viale dell'Università 2, 35020 Legnaro, Italy.
| | - Luca Morselli
- Legnaro National Laboratories, National Institute for Nuclear Physics, INFN-LNL, Viale dell'Università 2, 35020 Legnaro, Italy; Department of Physics and Earth Science, University of Ferrara, Via G. Saragat 1, 44121 Ferrara, Italy.
| | - Francesco Paolo Cammarata
- Institute of Molecular Bioimaging and Physiology, National Research Council. IBFM-CNR, Contrada Pietrapollastra-Pisciotto, 90015 Cefalù, Italy; Laboratori Nazionali del Sud, National Institute for Nuclear Physics, INFN-LNS, Via Santa Sofia 62, 95123 Catania, Italy.
| | - Albert Comelli
- Ri.MED Foundation, Via Bandiera 11, 90133 Palermo, Italy.
| | - Giorgio Russo
- Institute of Molecular Bioimaging and Physiology, National Research Council. IBFM-CNR, Contrada Pietrapollastra-Pisciotto, 90015 Cefalù, Italy; Laboratori Nazionali del Sud, National Institute for Nuclear Physics, INFN-LNS, Via Santa Sofia 62, 95123 Catania, Italy.
| | - Fabrizio Scopelliti
- Nuclear Medicine Department of Cannizzaro Hospital, Via Messina 829, 95126 Catania, Italy.
| | - Valerio Di Marco
- Department of Chemical Sciences, University of Padova, Via Marzolo 1, 35131 Padova, Italy.
| | - Francesca Mastrotto
- Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Via Marzolo 5, 35131 Padova, Italy.
| | - Mattia Asti
- Radiopharmaceutical Chemistry Section, Nuclear Medicine Unit, AUSL-IRCCS di Reggio Emilia, Viale Risorgimento 80, 42122 Reggio Emilia, Italy.
| | - Devid Maniglio
- Department of Industrial Engineering, BIOtech Research Center, University of Trento, Via delle Regole 101, 38123 Mattarello, Italy.
| | - Carla Sbarra
- Bologna Division, National Institute for Nuclear Physics, Viale C. Berti Pichat 6/2, 40127 Bologna, Italy.
| | - Silva Bortolussi
- Department of Physics, University of Pavia, Via Bassi 6, 27100 Pavia, Italy.
| | - Antonietta Donzella
- Department of Mechanical and Industrial Engineering, University of Brescia, Via Branze 38, 25123 Brescia, Italy; Pavia Division, National Institute for Nuclear Physics, Via Bassi 6, 27100 Pavia, Italy.
| | - Aldo Zenoni
- Department of Mechanical and Industrial Engineering, University of Brescia, Via Branze 38, 25123 Brescia, Italy; Pavia Division, National Institute for Nuclear Physics, Via Bassi 6, 27100 Pavia, Italy.
| | - Andrea Gandini
- Applied Nuclear Energy Laboratory, LENA, Via G. Aselli 41, 27100 Pavia, Italy.
| | - Valerio Villa
- Department of Mechanical and Industrial Engineering, University of Brescia, Via Branze 38, 25123 Brescia, Italy; Pavia Division, National Institute for Nuclear Physics, Via Bassi 6, 27100 Pavia, Italy.
| | - Diego Paderno
- Department of Mechanical and Industrial Engineering, University of Brescia, Via Branze 38, 25123 Brescia, Italy; Pavia Division, National Institute for Nuclear Physics, Via Bassi 6, 27100 Pavia, Italy.
| | - Lisa Zangrando
- Padova Division, National Institute for Nuclear Physics, Via Marzolo 8, 35131 Padova, Italy.
| | - Stefano Corradetti
- Legnaro National Laboratories, National Institute for Nuclear Physics, INFN-LNL, Viale dell'Università 2, 35020 Legnaro, Italy.
| | - Emilio Mariotti
- Department of Physical Sciences, Earth and Environment, University of Siena, Via Roma 56, 53100 Siena, Italy; Pisa Division, National Institute for Nuclear Physics, Largo Bruno Pontecorvo 3, 56127 Pisa, Italy.
| | - Andrea Salvini
- Applied Nuclear Energy Laboratory, LENA, Via G. Aselli 41, 27100 Pavia, Italy.
| | - Filippo Torrisi
- Department of Medicine and Surgery, University of Enna "Kore", Via Marzolo 8, 35131 Enna, Italy.
| | - Marcello Lunardon
- Department of Physics and Astronomy, University of Padova, Via Marzolo 8, 35131 Padova, Italy; Padova Division, National Institute for Nuclear Physics, Via Marzolo 8, 35131 Padova, Italy.
| | - Alberto Andrighetto
- Legnaro National Laboratories, National Institute for Nuclear Physics, INFN-LNL, Viale dell'Università 2, 35020 Legnaro, Italy.
| |
Collapse
|
3
|
Mellinger AL, Muddiman DC, Gamcsik MP. Highlighting Functional Mass Spectrometry Imaging Methods in Bioanalysis. J Proteome Res 2022; 21:1800-1807. [PMID: 35749637 DOI: 10.1021/acs.jproteome.2c00220] [Citation(s) in RCA: 7] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
Most mass spectrometry imaging (MSI) methods provide a molecular map of tissue content but little information on tissue function. Mapping tissue function is possible using several well-known examples of "functional imaging" such as positron emission tomography and functional magnetic resonance imaging that can provide the spatial distribution of time-dependent biological processes. These functional imaging methods represent the net output of molecular networks influenced by local tissue environments that are difficult to predict from molecular/cellular content alone. However, for decades, MSI methods have also been demonstrated to provide functional imaging data on a variety of biological processes. In fact, MSI exceeds some of the classic functional imaging methods, demonstrating the ability to provide functional data from the nanoscale (subcellular) to whole tissue or organ level. This Perspective highlights several examples of how different MSI ionization and detection technologies can provide unprecedented detailed spatial maps of time-dependent biological processes, namely, nucleic acid synthesis, lipid metabolism, bioenergetics, and protein metabolism. By classifying various MSI methods under the umbrella of "functional MSI", we hope to draw attention to both the unique capabilities and accessibility with the aim of expanding this underappreciated field to include new approaches and applications.
Collapse
Affiliation(s)
- Allyson L Mellinger
- FTMS Laboratory for Human Health Research, Department of Chemistry, North Carolina State University, Raleigh, North Carolina 27695, United States
| | - David C Muddiman
- FTMS Laboratory for Human Health Research, Department of Chemistry, North Carolina State University, Raleigh, North Carolina 27695, United States.,Molecular Education, Technology and Research Innovation Center (METRIC), North Carolina State University, Raleigh, North Carolina 27695, United States
| | - Michael P Gamcsik
- UNC/NCSU Joint Department of Biomedical Engineering, Raleigh, North Carolina 27695, United States
| |
Collapse
|